<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>http://groups.google.com/group/amn107</id>
  <title type="text">AMN107 Google Group</title>
  <subtitle type="text">
  AMN107
  </subtitle>
  <link href="/group/amn107/feed/atom_v1_0_msgs.xml" rel="self" title="AMN107 feed"/>
  <updated>2006-02-02T15:49:12Z</updated>
  <generator uri="http://groups.google.com" version="1.99">Google Groups</generator>
  <entry>
  <author>
  <name>Rob</name>
  <email>r...@neworleansemail.com</email>
  </author>
  <updated>2006-02-02T15:49:12Z</updated>
  <id>http://groups.google.com/group/amn107/browse_thread/thread/93f21e44ffb30b26/28d55bb39cbbfd44?show_docid=28d55bb39cbbfd44</id>
  <link href="http://groups.google.com/group/amn107/browse_thread/thread/93f21e44ffb30b26/28d55bb39cbbfd44?show_docid=28d55bb39cbbfd44"/>
  <title type="text">RSS &amp; Atom Feeds</title>
  <summary type="html" xml:space="preserve">
    &lt;br&gt; &lt;p&gt;	* Atom 1.0 * &lt;br&gt; 15 New messages &amp;lt;&lt;a target=&quot;_blank&quot; rel=nofollow href=&quot;http://groups.google.com/group/AMN107/feed/atom_v1_0_msgs.xml&quot;&gt;[link]&lt;/a&gt;&amp;gt; &lt;br&gt; 50 New messages &amp;lt;&lt;a target=&quot;_blank&quot; rel=nofollow href=&quot;http://groups.google.com/group/AMN107/feed/atom_v1_0_msgs.xml?num=50&quot;&gt;[link]&lt;/a&gt;&amp;gt; &lt;br&gt; 15 New topics &amp;lt;&lt;a target=&quot;_blank&quot; rel=nofollow href=&quot;http://groups.google.com/group/AMN107/feed/atom_v1_0_topics.xml&quot;&gt;[link]&lt;/a&gt;&amp;gt; &lt;br&gt; 50 New topics &amp;lt;&lt;a target=&quot;_blank&quot; rel=nofollow href=&quot;http://groups.google.com/group/AMN107/feed/atom_v1_0_topics.xml?num=50&quot;&gt;[link]&lt;/a&gt;&amp;gt;
  </summary>
  </entry>
  <entry>
  <author>
  <name>Rob</name>
  <email>r...@robwire.com</email>
  </author>
  <updated>2005-09-11T21:36:10Z</updated>
  <id>http://groups.google.com/group/amn107/browse_thread/thread/fc5df8c44d5922a1/792c38110da0be78?show_docid=792c38110da0be78</id>
  <link href="http://groups.google.com/group/amn107/browse_thread/thread/fc5df8c44d5922a1/792c38110da0be78?show_docid=792c38110da0be78"/>
  <title type="text">[AMN107] New Articles Posted On CML Newswire</title>
  <summary type="html" xml:space="preserve">
  I have posted over 30 new articles today at &lt;a target=&quot;_blank&quot; rel=nofollow href=&quot;http://cmlsupport.blogspot.com&quot;&gt;[link]&lt;/a&gt; on various news CML studies and developments. I am still trying to get back to a normal schedule after the past 2 weeks from Hurricane Katrina. &lt;br&gt; Rob
  </summary>
  </entry>
  <entry>
  <author>
  <name>Barbara Marfleet</name>
  <email>barb...@marfleet.fsnet.co.uk</email>
  </author>
  <updated>2005-08-20T16:57:49Z</updated>
  <id>http://groups.google.com/group/amn107/browse_thread/thread/bfa116ffc5544faf/ff582002d065a1bc?show_docid=ff582002d065a1bc</id>
  <link href="http://groups.google.com/group/amn107/browse_thread/thread/bfa116ffc5544faf/ff582002d065a1bc?show_docid=ff582002d065a1bc"/>
  <title type="text">[AMN107] Toxicity</title>
  <summary type="html" xml:space="preserve">
  Dear Anjana &lt;br&gt; Thankyou for your message.I will only be able to contemplate going back on the AMN 107, if Novartis allows me to take a much-reduced dose, as the 400 mg is much too toxic, and I have had to stop taking it until I go bak to Newcastle next Wednesday. Keep in touch and I will let you know what happens.
  </summary>
  </entry>
  <entry>
  <author>
  <name>Anjana</name>
  <email>anj...@pacific.net.sg</email>
  </author>
  <updated>2005-08-19T17:30:28Z</updated>
  <id>http://groups.google.com/group/amn107/browse_thread/thread/d29136c0e584ce21/09b490e13421eb80?show_docid=09b490e13421eb80</id>
  <link href="http://groups.google.com/group/amn107/browse_thread/thread/d29136c0e584ce21/09b490e13421eb80?show_docid=09b490e13421eb80"/>
  <title type="text">[AMN107] AMN107 Toxicity</title>
  <summary type="html" xml:space="preserve">
  Dear Barbara, &lt;br&gt; &lt;p&gt; My husband is on Gleevec and doing well, I am a friend of Ruth&#39;s. AMN107 &lt;br&gt; trials are soon to start in Singapore where we live and our doctor was &lt;br&gt; asking if any AMN107 patients I know have suffered adverse side-effects. &lt;br&gt; Would you mind sharing your side-effects with us? &lt;br&gt; &lt;p&gt; As far as I know, the AMN107 trial protocol for Phase I had escalating
  </summary>
  </entry>
  <entry>
  <author>
  <name>Barbara Marfleet</name>
  <email>barb...@marfleet.fsnet.co.uk</email>
  </author>
  <updated>2005-08-19T11:22:44Z</updated>
  <id>http://groups.google.com/group/amn107/browse_thread/thread/bfa116ffc5544faf/a39fc683dbea7c4b?show_docid=a39fc683dbea7c4b</id>
  <link href="http://groups.google.com/group/amn107/browse_thread/thread/bfa116ffc5544faf/a39fc683dbea7c4b?show_docid=a39fc683dbea7c4b"/>
  <title type="text">[AMN107] Toxicity</title>
  <summary type="html" xml:space="preserve">
  Is anyone out there on a smaller dose than 400mg? I have had to stop the drug for the time being, as it seems to be too toxic for me. My consultant is away till next week, so I had no-one to ask for advice. &lt;br&gt; Feeling very despondent about it. Anyone else had a similar experience? &lt;br&gt; Best Wishes,
  </summary>
  </entry>
  <entry>
  <author>
  <name>Rob</name>
  <email>r...@rwneill.com</email>
  </author>
  <updated>2005-08-03T02:48:07Z</updated>
  <id>http://groups.google.com/group/amn107/browse_thread/thread/55a849a2c2614cc6/412b5bd09fd436a6?show_docid=412b5bd09fd436a6</id>
  <link href="http://groups.google.com/group/amn107/browse_thread/thread/55a849a2c2614cc6/412b5bd09fd436a6?show_docid=412b5bd09fd436a6"/>
  <title type="text">Re: [AMN107] Barbara</title>
  <summary type="html" xml:space="preserve">
  I hope it will continue to go well Barbara. &lt;br&gt; &lt;p&gt;Rob &lt;br&gt; ----- Original Message ----- &lt;br&gt; From: Barbara Marfleet &lt;br&gt; To: AMN...@cmlhope.com &lt;br&gt; Sent: Tuesday, August 02, 2005 4:11 PM &lt;br&gt; Subject: [AMN107] Barbara &lt;br&gt; &lt;p&gt; Into my second month on AMN107 now. Not totally without problems, but largely caused by the complete change-over for one&#39;s poor body!! Hope this message gets to someone who finds it useful,
  </summary>
  </entry>
  <entry>
  <author>
  <name>Barbara Marfleet</name>
  <email>barb...@marfleet.fsnet.co.uk</email>
  </author>
  <updated>2005-08-02T21:11:37Z</updated>
  <id>http://groups.google.com/group/amn107/browse_thread/thread/55a849a2c2614cc6/de5fb2b117abe626?show_docid=de5fb2b117abe626</id>
  <link href="http://groups.google.com/group/amn107/browse_thread/thread/55a849a2c2614cc6/de5fb2b117abe626?show_docid=de5fb2b117abe626"/>
  <title type="text">[AMN107] Barbara</title>
  <summary type="html" xml:space="preserve">
  Into my second month on AMN107 now. Not totally without problems, but largely caused by the complete change-over for one&#39;s poor body!! Hope this message gets to someone who finds it useful, &lt;br&gt; Regards, &lt;br&gt; Barbara, U,K.
  </summary>
  </entry>
  <entry>
  <author>
  <name>Rob</name>
  <email>r...@robwire.com</email>
  </author>
  <updated>2005-07-31T02:57:44Z</updated>
  <id>http://groups.google.com/group/amn107/browse_thread/thread/954481679db6bde5/ef640aae25952575?show_docid=ef640aae25952575</id>
  <link href="http://groups.google.com/group/amn107/browse_thread/thread/954481679db6bde5/ef640aae25952575?show_docid=ef640aae25952575"/>
  <title type="text">[AMN107] New Clinical Trials Now Recruiting For VX-680 For T315I Mutation</title>
  <summary type="html" xml:space="preserve">
  Clinical trials are now recruiting patients for the new Merck drug VX-680 which has been developed to work on the T315I mutation. There are 3 separate trials that are now open with trial locations in Texas, Massachusetts, New Jersey, Pennsylvania, and Wisconsin. CML patients who have failed on Gleevec, AMN107, and BMS354825 may be eligible for this trial. This is a potentially a very important drug for CML patients because it may work on the T315I mutation. If you know of any CML patients with the T315I mutation let them know about these trial locations so can find out if they may be eligible.
  </summary>
  </entry>
  <entry>
  <author>
  <name>Rob</name>
  <email>r...@robwire.com</email>
  </author>
  <updated>2005-07-30T19:40:58Z</updated>
  <id>http://groups.google.com/group/amn107/browse_thread/thread/dd72c1aaba43ed0d/1e05a405a596f2a3?show_docid=1e05a405a596f2a3</id>
  <link href="http://groups.google.com/group/amn107/browse_thread/thread/dd72c1aaba43ed0d/1e05a405a596f2a3?show_docid=1e05a405a596f2a3"/>
  <title type="text">[AMN107] New Novartis CML Clinical Trials</title>
  <summary type="html" xml:space="preserve">
  2) Novartis Oncology is studying an investigational drug in patients with &lt;br&gt; different types of Leukemia and blood malignancies.. This study is being &lt;br&gt; conducted in: &lt;br&gt; - Tampa, FL &lt;a target=&quot;_blank&quot; rel=nofollow href=&quot;http://www.centerwatch.com/patient/studies/stu80447.html&quot;&gt;[link]&lt;/a&gt; &lt;br&gt; - Chicago, IL &lt;a target=&quot;_blank&quot; rel=nofollow href=&quot;http://www.centerwatch.com/patient/studies/stu80448.html&quot;&gt;[link]&lt;/a&gt;
  </summary>
  </entry>
  <entry>
  <author>
  <name>Rob</name>
  <email>r...@robwire.com</email>
  </author>
  <updated>2005-07-27T07:00:44Z</updated>
  <id>http://groups.google.com/group/amn107/browse_thread/thread/da09dc07029b4ded/16aa608b28e065aa?show_docid=16aa608b28e065aa</id>
  <link href="http://groups.google.com/group/amn107/browse_thread/thread/da09dc07029b4ded/16aa608b28e065aa?show_docid=16aa608b28e065aa"/>
  <title type="text">[AMN107] New Drug For T315I Mutation Which Causes Gleevec Resistance</title>
  <summary type="html" xml:space="preserve">
  New Drug For T315I Mutation Which Causes Gleevec Resistance &lt;br&gt; &lt;p&gt;Ambit Biosciences has announced the discovery of a new drug that may work on the T315I &lt;br&gt; mutation which causes Gleevec resistance in CML patients. This may become another &lt;br&gt; important new drug in the CML pipeline. &lt;br&gt; &lt;p&gt;&lt;a target=&quot;_blank&quot; rel=nofollow href=&quot;http://cmlhope.com/?q=node/72&quot;&gt;[link]&lt;/a&gt;
  </summary>
  </entry>
  <entry>
  <author>
  <name>Rob</name>
  <email>r...@robwire.com</email>
  </author>
  <updated>2005-07-23T22:34:45Z</updated>
  <id>http://groups.google.com/group/amn107/browse_thread/thread/79f5c1484e943bb9/01e2524e4a1eb410?show_docid=01e2524e4a1eb410</id>
  <link href="http://groups.google.com/group/amn107/browse_thread/thread/79f5c1484e943bb9/01e2524e4a1eb410?show_docid=01e2524e4a1eb410"/>
  <title type="text">[AMN107] Human beings!</title>
  <summary type="html" xml:space="preserve">
  ----- Original Message ----- &lt;br&gt; To: AMN107-ow...@cmlhope.com &lt;br&gt; Sent: Saturday, July 23, 2005 11:29 AM &lt;br&gt; &lt;p&gt;I am one of the first people to be on the trials of AMN107, in England. Have managed to find one person in the States (Ruth) to chat to, and one person who is about to be assessed in Tampa (Amy).We call ourselves The Three Musketeers!
  </summary>
  </entry>
  <entry>
  <author>
  <name>Rob</name>
  <email>r...@robwire.com</email>
  </author>
  <updated>2005-07-23T03:39:52Z</updated>
  <id>http://groups.google.com/group/amn107/browse_thread/thread/9e924498b597687b/2f53da9ba4042d2a?show_docid=2f53da9ba4042d2a</id>
  <link href="http://groups.google.com/group/amn107/browse_thread/thread/9e924498b597687b/2f53da9ba4042d2a?show_docid=2f53da9ba4042d2a"/>
  <title type="text">[AMN107] The small molecule tyrosine kinase inhibitor AMN107 inhibits TEL-PDGFR{beta} and FIP1L1-PDGFR{alpha} in vitro and in vivo</title>
  <summary type="html" xml:space="preserve">
  AMN107 is a small molecule tyrosine kinase inhibitor developed, in the first instance, as a potent inhibitor of BCR-ABL. We tested its effectiveness against fusion tyrosine kinases TEL-PDGFRbeta and FIP1L1-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively. In vitro, AMN107 inhibited proliferation of Ba/F3 cells transformed by both TEL-PDGFRbeta and FIP1L1-PDGFRalpha with IC50 values &amp;lt; 25 nM, and inhibited phosphorylation of the fusion kinases and their downstream signaling targets.
  </summary>
  </entry>
  <entry>
  <author>
  <name>Rob</name>
  <email>r...@robwire.com</email>
  </author>
  <updated>2005-07-08T18:18:38Z</updated>
  <id>http://groups.google.com/group/amn107/browse_thread/thread/b6133d516d658efe/bc64241708ed0085?show_docid=bc64241708ed0085</id>
  <link href="http://groups.google.com/group/amn107/browse_thread/thread/b6133d516d658efe/bc64241708ed0085?show_docid=bc64241708ed0085"/>
  <title type="text">[AMN107] AMN107, a Novel Aminopyrimidine Inhibitor of Bcr-Abl, Has In vitro Activity against Imatinib-Resistant Chronic Myeloid Leukemia.</title>
  <summary type="html" xml:space="preserve">
  Resistance to or intolerance of imatinib in patients with Philadelphia chromosome-positive chronic myelogenous leukemia (CML) has encouraged the development of more potent Bcr-Abl inhibitors. AMN107 is a novel, orally bioavailable ATP-competitive inhibitor of Bcr-Abl. The effects of AMN107 were compared with those of imatinib on imatinib-sensitive (KBM5 and KBM7) and imatinib-resistant CML cell lines (KBM5-STI571(R1.0) and KBM7-STI571(R1.0)).
  </summary>
  </entry>
  <entry>
  <author>
  <name>Rob</name>
  <email>r...@rwneill.com</email>
  </author>
  <updated>2005-06-28T02:54:25Z</updated>
  <id>http://groups.google.com/group/amn107/browse_thread/thread/c690276e27913ad4/de1819a5e83c4849?show_docid=de1819a5e83c4849</id>
  <link href="http://groups.google.com/group/amn107/browse_thread/thread/c690276e27913ad4/de1819a5e83c4849?show_docid=de1819a5e83c4849"/>
  <title type="text">Re: [AMN107] 6/13 bone marrow results</title>
  <summary type="html" xml:space="preserve">
  That is great to hear you are doing well Ruth. &lt;br&gt; &lt;p&gt;Rob &lt;br&gt; ----- Original Message ----- &lt;br&gt; From: Ruth McIntosh &lt;br&gt; To: AMN...@cmlhope.com &lt;br&gt; Sent: Monday, June 27, 2005 1:32 PM &lt;br&gt; Subject: [AMN107] 6/13 bone marrow results &lt;br&gt; &lt;p&gt; Just wanted you to know I am still in CCR since 12/28/04 and on only 400mg of AMN107 once daily. Hugs, Ruth
  </summary>
  </entry>
  <entry>
  <author>
  <name>AMY BAKER</name>
  <email>ambak...@msn.com</email>
  </author>
  <updated>2005-06-28T02:37:14Z</updated>
  <id>http://groups.google.com/group/amn107/browse_thread/thread/c690276e27913ad4/954d7db078d08b28?show_docid=954d7db078d08b28</id>
  <link href="http://groups.google.com/group/amn107/browse_thread/thread/c690276e27913ad4/954d7db078d08b28?show_docid=954d7db078d08b28"/>
  <title type="text">Re: [AMN107] 6/13 bone marrow results</title>
  <summary type="html" xml:space="preserve">
  Dear Ruth, CONGRATULATIONS!!! I am so very happy for you. What great news. Hugs to you. Amy &lt;br&gt; ----- Original Message ----- &lt;br&gt; From: Ruth McIntosh&amp;lt;mailto:greatgranny22. ..@yahoo.com&amp;gt; &lt;br&gt; To: AMN...@cmlhope.com&amp;lt;mailto:AMN. ..@cmlhope.com&amp;gt; &lt;br&gt; Sent: Monday, June 27, 2005 2:32 PM &lt;br&gt; Subject: [AMN107] 6/13 bone marrow results
  </summary>
  </entry>
  <entry>
  <author>
  <name>Ruth McIntosh</name>
  <email>greatgranny22...@yahoo.com</email>
  </author>
  <updated>2005-06-27T18:32:57Z</updated>
  <id>http://groups.google.com/group/amn107/browse_thread/thread/c690276e27913ad4/298ffd0711b94883?show_docid=298ffd0711b94883</id>
  <link href="http://groups.google.com/group/amn107/browse_thread/thread/c690276e27913ad4/298ffd0711b94883?show_docid=298ffd0711b94883"/>
  <title type="text">[AMN107] 6/13 bone marrow results</title>
  <summary type="html" xml:space="preserve">
  Just wanted you to know I am still in CCR since 12/28/04 and on only 400mg of AMN107 once daily. Hugs, Ruth &lt;br&gt; &lt;p&gt;This is my email from MDACC &lt;br&gt; &lt;p&gt;Dear Ruth: Once again it is my pleasure to inform you of a complete cytogenetic remission. Congratulations and of course we are very happy for you &lt;br&gt; &lt;p&gt;Twenty normal female metaphases are analyzed. No apparent abnormal clone
  </summary>
  </entry>
  <entry>
  <author>
  <name>Rob</name>
  <email>r...@rwneill.com</email>
  </author>
  <updated>2005-06-25T07:44:09Z</updated>
  <id>http://groups.google.com/group/amn107/browse_thread/thread/e4c019f7815e9165/91aa285ac756edcc?show_docid=91aa285ac756edcc</id>
  <link href="http://groups.google.com/group/amn107/browse_thread/thread/e4c019f7815e9165/91aa285ac756edcc?show_docid=91aa285ac756edcc"/>
  <title type="text">Re: [AMN107] AMN107</title>
  <summary type="html" xml:space="preserve">
  AMN107 is the new drug in clinical trials from Novartis for patients who do not respond well on Gleevec. Here are some sites which have some information &lt;br&gt; &lt;p&gt;&lt;a target=&quot;_blank&quot; rel=nofollow href=&quot;http://www.novartisoncology.com/page/amn107.jsp&quot;&gt;[link]&lt;/a&gt; &lt;br&gt; &lt;p&gt;&lt;a target=&quot;_blank&quot; rel=nofollow href=&quot;http://patient.cancerconsultants.com/leukemia_cancer_news.aspx?id=34015&quot;&gt;[link]&lt;/a&gt;
  </summary>
  </entry>
  <entry>
  <author>
  <name>AMY BAKER</name>
  <email>ambak...@msn.com</email>
  </author>
  <updated>2005-06-25T03:32:37Z</updated>
  <id>http://groups.google.com/group/amn107/browse_thread/thread/e4c019f7815e9165/b92b66baf91f679a?show_docid=b92b66baf91f679a</id>
  <link href="http://groups.google.com/group/amn107/browse_thread/thread/e4c019f7815e9165/b92b66baf91f679a?show_docid=b92b66baf91f679a"/>
  <title type="text">Re: [AMN107] AMN107</title>
  <summary type="html" xml:space="preserve">
  Thanks for writing, Rob. I couldn&#39;t access any info on the AMN107 site. It this a brand new site or am I doing something wrong? I&#39;m very new to all this. Amy &lt;br&gt; ----- Original Message ----- &lt;br&gt; From: Rob&amp;lt;mailto:r...@rwneill.com&amp;gt; &lt;br&gt; To: AMN...@cmlhope.com&amp;lt;mailto:AMN. ..@cmlhope.com&amp;gt; &lt;br&gt; Sent: Friday, June 24, 2005 11:26 PM
  </summary>
  </entry>
  <entry>
  <author>
  <name>Rob</name>
  <email>r...@rwneill.com</email>
  </author>
  <updated>2005-06-25T03:26:50Z</updated>
  <id>http://groups.google.com/group/amn107/browse_thread/thread/e4c019f7815e9165/455ae75e4392f6ae?show_docid=455ae75e4392f6ae</id>
  <link href="http://groups.google.com/group/amn107/browse_thread/thread/e4c019f7815e9165/455ae75e4392f6ae?show_docid=455ae75e4392f6ae"/>
  <title type="text">Re: [AMN107] AMN107</title>
  <summary type="html" xml:space="preserve">
  The results that have been released so far on the trial have been good. &lt;br&gt; &lt;p&gt;Rob &lt;br&gt; &lt;p&gt; ----- Original Message ----- &lt;br&gt; From: AMY BAKER &lt;br&gt; To: AMN...@cmlhope.com &lt;br&gt; Sent: Friday, June 24, 2005 6:34 AM &lt;br&gt; Subject: [AMN107] AMN107 &lt;br&gt; &lt;p&gt; I have CML and I&#39;m being considered for an AMN107 trial at the Moffitt Cancer Center in Tampa, FL. Has anyone tried this compound previously and, if so, what were the results? Thanks. Amy Baker
  </summary>
  </entry>
  <entry>
  <author>
  <name>AMY BAKER</name>
  <email>ambak...@msn.com</email>
  </author>
  <updated>2005-06-24T11:34:40Z</updated>
  <id>http://groups.google.com/group/amn107/browse_thread/thread/e4c019f7815e9165/6a0de94381b06316?show_docid=6a0de94381b06316</id>
  <link href="http://groups.google.com/group/amn107/browse_thread/thread/e4c019f7815e9165/6a0de94381b06316?show_docid=6a0de94381b06316"/>
  <title type="text">[AMN107] AMN107</title>
  <summary type="html" xml:space="preserve">
  I have CML and I&#39;m being considered for an AMN107 trial at the Moffitt Cancer Center in Tampa, FL. Has anyone tried this compound previously and, if so, what were the results? Thanks. Amy Baker
  </summary>
  </entry>
  <entry>
  <author>
  <name>Rob</name>
  <email>r...@rwneill.com</email>
  </author>
  <updated>2005-06-22T18:31:45Z</updated>
  <id>http://groups.google.com/group/amn107/browse_thread/thread/3c16901f6fe0348e/77b4a26cf9b266ec?show_docid=77b4a26cf9b266ec</id>
  <link href="http://groups.google.com/group/amn107/browse_thread/thread/3c16901f6fe0348e/77b4a26cf9b266ec?show_docid=77b4a26cf9b266ec"/>
  <title type="text">Re: [AMN107] Diagnosis</title>
  <summary type="html" xml:space="preserve">
  Welcome to the group Ruth. We are hoping to get some discussion here &lt;br&gt; on the trials. &lt;br&gt; &lt;p&gt;Rob &lt;br&gt; ----- Original Message ----- &lt;br&gt; From: Ruth McIntosh &lt;br&gt; To: AMN...@cmlhope.com &lt;br&gt; Sent: Wednesday, June 22, 2005 11:56 AM &lt;br&gt; Subject: [AMN107] Diagnosis &lt;br&gt; &lt;p&gt; It seems I may be the first to post on the AMN107 site for cmlhope. I really pray others on the AMN107 drug will also post as I really don&#39;t have anyone to compare notes with.
  </summary>
  </entry>
  <entry>
  <author>
  <name>Ruth McIntosh</name>
  <email>greatgranny22...@yahoo.com</email>
  </author>
  <updated>2005-06-22T16:56:06Z</updated>
  <id>http://groups.google.com/group/amn107/browse_thread/thread/3c16901f6fe0348e/59d400e1ca157475?show_docid=59d400e1ca157475</id>
  <link href="http://groups.google.com/group/amn107/browse_thread/thread/3c16901f6fe0348e/59d400e1ca157475?show_docid=59d400e1ca157475"/>
  <title type="text">[AMN107] Diagnosis</title>
  <summary type="html" xml:space="preserve">
  It seems I may be the first to post on the AMN107 site for cmlhope. I really pray others on the AMN107 drug will also post as I really don&#39;t have anyone to compare notes with. &lt;br&gt; I was diagnosed with CML on 2/28/04 after being hospitalized due to severe left shoulder and arm pain which the doc thought may be the beginning of a heart attack. My WBC was 82000 on Thursday and an oncologist was consulted. We live in a small town and I had just retired from a surgery office. One of my &amp;quot;surgeons&amp;quot; came by and talked with me and gave me more advise and info that any of the other docs had. By then it was 5PM on Friday and I was being discharged. My surgeon called a cancer clinic about 65 miles away and had me an appointment for Tuesday, March 2, 2004 and CML was confirmed by bone marrow. On that day my WBC was 135000.
  </summary>
  </entry>
</feed>
